Expert Opinion on Drug Safety
Volume 23, 2024 - Issue 6
Original Research
COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan®) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT)
Stylianos Kandarakisa First Department of Ophthalmology, G. Gennimatas Hospital, National and Kapodistrian University of Athens, Athens, GreeceCorrespondence[email protected]
https://orcid.org/0000-0003-2912-7438View further author information
https://orcid.org/0000-0003-2912-7438View further author information, , , , , , , Nefeli Ioanna Paizib Ophthalmo Check Eye Center, Athens, Greecehttps://orcid.org/0009-0009-1030-5135View further author information
https://orcid.org/0009-0009-1030-5135View further author information, & show all